From Metabolism to Mechanism, Profile PRMT5 Activity in Cancer Profile PRMT5 activity with precise SDMA/ADMA quantification and full methionine cycle coverage. Support inhibitor development, patient stratification, and tumor profiling.
Beyond Plaques and Tangles: How Untargeted Metabolomics Detects Distinct Signatures in Alzheimer’s Disease Untargeted metabolomics captures systemic metabolic changes in neurodegenerative diseases, such as Alzheimer’s, identifying altered pathways and metabolites for research and therapy.
Unlocking FFPE Archives: How TissueBridge™️ Enables Retrospective Profiling of Tumor Metabolism Panome Bio’s TissueBridge technology unlocks the full metabolomic potential of FFPE tissue archives, enabling comprehensive, high-confidence profiling of tumor metabolism for biomarker discovery, translational research, and retrospective clinical studies.
Comprehensive Biological Profiling in Cancer via Multi-Omics Integration Colorectal cancer is on the rise and remains difficult to detect and treat. Panome Bio’s multi-omics platform combines metabolomics and proteomics to reveal how molecules interact across metabolic pathways and biological networks. This approach uncovers novel biomarkers and therapeutic targets, offering a deeper understanding of cancer biology […]
Dive into the power of Panome Bio’s Next-Generation Metabolomics in this sample data report. See how Panome Bio used untargeted metabolomics workflow to analyze tumor and normal adjacent tissue from fresh-frozen samples.
Combining Metabolomics, Proteomics and Transcriptomics to Reveal Key Pathways and Biomarkers Explore how reduced KRAS activity reshapes gene expression and pathway activity in HCT-116 cells. In this application note, Panome Bio combines next-generation metabolomics, global proteomics, phosphoproteomics and mRNA sequencing data into a multi-omics framework to deliver in-depth biochemical pathway analyses for potential therapeutic targeting.
Metabolic Profiling of Tumor and Normal Adjacent FFPE Tissue Panome Bio is excited to announce a new, fully validated service that brings comprehensive, untargeted metabolomics to formalin-fixed paraffin-embedded (FFPE) samples, TissueBridge Metabolomics. Expanding the power of the Next-Generation Metabolomics platform, Panome Bio provides researchers with an unprecedented opportunity to access metabolic data from fresh to […]
Dive into the power of TissueBridge from Panome Bio in this sample data report. See how Panome Bio used TissueBridge – a novel Next-Generation Metabolomics workflow to analyze tumor and normal adjacent tissue from FFPE samples.
Comprehensive Metabolite Profiling of FFPE Tissue Samples This poster presentation includes an in-house study directly comparing FFPE tissue with fresh frozen samples using our Next-Generation Metabolomics platform. The results of the study indicate metabolic signatures from FFPE samples are not only robust but also biologically relevant, validating FFPE as a reliable source for metabolomic insights.
Next-Generation Metabolomics for Dried Blood Spot Analysis Next-Generation Metabolomics can provide robust, biologically meaningful data for dried blood spot analysis. Learn more about the coverage, stability and concordance of Panome Bio’s methods in this application note.